← NDC directory

FDA compounder NDC directory

Browse every current FDA compounder source row, including records that do not contain a usable NDC.

Compounder NDC directory#

Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.

Compounder directory page 206 of 669 · 33,450 matching rows.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCBrandNonproprietary nameActive ingredientsPeriodNormalizationSource date
Nubratori Inc.71300-662271300-6622-5LIDOCAINE HCL AND TETRACAINE HCLLidocaine HCl and Tetracaine HCl4 mg/1 mL; 2 mg/1 mL2024-2valid2026-09-18
Nubratori Inc.71300-661071300-6610-9NALTREXONE HYDROCHLORIDENALTREXONE HYDROCHLORIDE4.5 mg2024-2valid2026-09-18
Nubratori Inc.71300-661071300-6610-3NALTREXONE HYDROCHLORIDENALTREXONE HYDROCHLORIDE4.5 mg2024-2valid2026-09-18
Nubratori Inc.71300-664771300-6647-3NALTREXONE HYDROCHLORIDENALTREXONE HYDROCHLORIDE4.5 mg2024-2valid2026-09-18
Nubratori Inc.71300-664771300-6647-9NALTREXONE HYDROCHLORIDENALTREXONE HYDROCHLORIDE4.5 mg2024-2valid2026-09-18
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .1 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .06 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .3 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate30 mg/1 mL; 3 mg/1 mL; .15 mg/1 mL; .2 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride2 mg/1 mL; .02 mg/1 mL; .2 mg/1 mL; 20 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .01 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride.59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride.59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride.59 mg/1 mL; .006 mg/1 mL; 17.65 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1 mg/1 mL; .025 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride.29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride.29 mg/1 mL; .0029 mg/1 mL; 8 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .06 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride1.5 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .03 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .3 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .3 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .05 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride4 mg/1 mL; .3 mg/1 mL; 40 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Papaverine Hydrochloride3 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08
OLYMPIA PHARMACY017674368Phentolamine Mesylate; Papaverine Hydrochloride3 mg/1 mL; 30 mg/1 mL2024-2source_no_ndc2026-11-08